S100A6 Protein Expression Is Different in Spitz Nevi and Melanomas Adriana Ribé, M.D., Ph.D., N

Total Page:16

File Type:pdf, Size:1020Kb

S100A6 Protein Expression Is Different in Spitz Nevi and Melanomas Adriana Ribé, M.D., Ph.D., N S100A6 Protein Expression is Different in Spitz Nevi and Melanomas Adriana Ribé, M.D., Ph.D., N. Scott McNutt, M.D. Dermatopathology Division, Department of Pathology, New York Presbyterian Hospital—Cornell University Weill Medical College, New York, New York and melanomas, without differences. In summary, The Spitz nevus is a benign melanocytic lesion that a simple immunohistochemical test for S100A6 pro- can be identified reliably in many cases by conven- tein differentiated between Spitz nevi, melanomas, tional histopathological criteria. However, there are and melanocytic nevi. This marker could be used subsets of Spitz nevi and of malignant melanoma when the distinction is very difficult or controver- that closely resemble each other and represent di- sial in routine studies, especially when there is a agnostic challenges. S100 proteins are of interest junctional component. Further molecular analyses because of their involvement in neoplastic pro- of the S100A6 protein and gene should be per- cesses and their genes are clustered in chromosome formed to study the underlying genetic bases for 1q21. Chromosome 1 contains mutations in several such differences. types of tumors, including melanomas. The expres- sion of different S100 proteins (A2, A6 and A8/A9 or KEY WORDS: Melanocyte, Melanoma, S100, A12) was examined in 42 Spitz nevi, 105 melano- S100A6, Spindle and epithelioid cell nevus, Spitz mas, and 73 melanocytic nevi to test the hypothesis nevus. that their expression differs among these entities Mod Pathol 2003;16(5):505–511 and may contribute to the distinction between these entities. The results showed an up-regulation of The epithelioid and spindle cell nevus was first S100A6 protein in Spitz nevi, melanomas, and mela- described in 1948 by Spitz and named juvenile mel- nocytic nevi but with a different percentage of pos- anoma (1). It is a benign melanocytic lesion found itivity and pattern of immunoreactivity. The differ- predominantly in children and adolescents and ences between these three entities were statistically that can be identified reliably in many cases by significant (P < .001). All 42 Spitz nevi (100%) previously well-described major and minor his- showed strong and diffuse S100A6 protein expres- topathological criteria (2–5). However, there are sion, both in junctional and in dermal components subsets of Spitz nevi and of malignant melanoma of the nevi. Thirty-three percent of melanomas ex- that closely resemble each other and represent di- pressed S100A6 (35/105). The expression was agnostic challenges. Additionally, some lesions are mainly weak (30/35) and patchy in the dermal com- only partially excised (shave biopsies), thus often ponent and was negative or minimal in the junc- preventing the assessment of the lateral edges and tional component. Fifty-six percent of different sub- deep components. The importance of distinguish- types of melanocytic nevi (41/73) expressed S100A6, ing between these two entities lies in their different almost all of them weakly (40/41) and in the dermal prognosis and treatment. Multiple studies using component. Normal intraepidermal melanocytes several approaches (immunohistochemistry, flow were negative. The melanocytic cells in these three cytometry and molecular analysis) have been per- entities did not express S100A2, S100A8/A9 or A12. formed to identify potential differences between However, an up-regulation of S100A2 and Spitz nevi and melanomas, but the results have S100A8/A9 or A12 proteins was observed in normal been controversial or difficult to apply to routine keratinocytes in the epidermis overlying Spitz nevi material (6–38). S100 protein is not a single protein; instead there are a group of S100 proteins with Copyright © 2003 by The United States and Canadian Academy of diverse functions. The S100 protein family, a sub- Pathology, Inc. 2ϩ VOL. 16, NO. 5, P. 505, 2003 Printed in the U.S.A. class of low molecular weight Ca -binding pro- Date of acceptance: January 24, 2003. teins, regulate a variety of cellular processes via Address reprint requests to: N. Scott McNutt, M.D., Dermatopathology (F- 309), Weill Medical Center of Cornell University, 1300 York Avenue, New interaction with different target proteins in a York, NY 10021; fax: 212-746-8570; e-mail: [email protected]. calcium-dependent manner. They are of interest DOI: 10.1097/01.MP.0000071128.67149.FD because of their involvement in neoplastic pro- 505 cesses and their genes are clustered in chromosome of positive lesional cells. Appropriate positive and 1q21. Chromosome 1 is frequently altered in several negative controls were also included. tumors, including melanomas (28, 39, 40). The The ␹2 test was used for comparison of groups. A most widely known commercially available anti- P value of Ͻ.05 was considered significant. body “anti-S100” mainly reacts with cells contain- ing S100B polypeptide chains. This antibody was used as an early marker for melanocytic neoplasms RESULTS and remains sensitive but not specific (41–43). Re- cently, monoclonal antibodies have become avail- All Spitz nevi cases (42/42) strongly expressed able that mainly react with S100aa and have iden- S100A6 protein in a diffuse pattern, regardless of tified several variants of the S100a chains (28). The the subtype (compound, dermal, or junctional; expression of different S100 proteins (A2, A6, and Figs. 1, 2). The melanocytic cells in all Spitz nevi A8/A9 or A12) was examined in Spitz nevi, melano- cases did not react with anti-S100A2 or MAC387 mas, and melanocytic nevi cases to test the hypoth- antibodies. However, the keratinocytes in the epi- esis that their expression differs among these enti- dermis overlying Spitz nevi reacted with anti- ties and may contribute to the distinction between S100A2 antibody in some cells in the basal layer and these entities. with the MAC387 antibody in some cells in the upper third of the epidermis. The HMB45 antibody was weakly positive on the junctional component, MATERIALS AND METHODS whereas the dermal component usually was nega- The cases were obtained from the files at the tive with only scattered positive cells. Dermatopathology Division of the New York Pres- S100A6 protein was expressed in 35 of 105 mela- byterian Hospital-Cornell University Weill Medical nomas (33%), 30 of them with weak positivity College, between 1997 and 2002, based on the avail- (86%). The distribution of positive cases in the mel- ability of adequate tissue material for study. Forty- anoma subtypes was as follows: 10 of 12 nodular two cases of Spitz nevi, 105 cases of melanomas, (83%), 3 of 7 metastatic (43%), 16 of 54 superficial and 73 cases of different types of melanocytic nevi spreading (30%), 2 of 7 lentigo maligna (28.5%), 3 of were selected. The diagnosis was made on multiple 21 in situ (14%), and 1 acral (Figs. 3, 4). Only 3 H&E routine-stained sections before this study. Af- nodular melanomas and 1 superficial spreading ter review of newly cut routine microscopic sec- and 1 acral melanoma were strongly positive. The tions, additional unstained sections were cut, expression in the positive melanoma cases was deparaffinized, pretreated with pepsin (0.25% w/v, patchy throughout the tumor and negative or min- pH 2.0) for 5 minutes at 45° C, and then reacted imal in the junctional component. Three desmo- with the monoclonal antibodies: anti-S100A2, anti- plastic melanomas were negative. In all melanoma S100A6, MAC387, and HMB45 (Table 1). A cases, the melanocytes did not stain with anti- streptavidin-alkaline phosphatase detection system S100A2 or MAC387 antibodies. However, S100A2 with a red chromogen (Vector Lab) was used. The protein was expressed in the keratinocytes located reaction time for the red chromogen was 20 min- in the basal or parabasal layer of the epidermis utes. Two investigators verified the results of the adjacent to melanoma cells and MAC387 antibody immunostains without references to the original was often observed in the full thickness of the over- diagnosis, although in some cases the diagnosis was lying epidermis. HMB45 was positive in some of the obvious. The staining was evaluated semiquantita- tively and read as positive (strong or weak) and negative. In the cases regarded as strongly positive, staining was observed in Ͼ50% of the lesional cells whereas the weakly, positive cells were between 1 and 50% positive. The negative cases showed Ͻ1% TABLE 1. Monoclonal Antibodies Used in this Study Antibody Clone Source Dilution Anti-S-100A2 (S100L) SH-L1 Sigma 1:1000 Anti-S-100A6 CACY-100 Sigma 1:1000 (calcyclin) Myeloid histiocyte MAC387 Dakopatts 1:100 antigen FIGURE 1. Spitz nevus. This photograph shows a strong and uniform HMB45, HMB45 DAKO 1:100 reactivity with the monoclonal antibody against S100A6 protein in the melanosome nevus cells. 506 Modern Pathology architectural disorder (88%), 6 of 12 combined nevi (50%), 3 of 6 blue nevi (50%), 5 of 13 compound nevi (38%), 4 of 12 intradermal nevi (33%), and 1 of 3 acral nevi (33%; Fig. 5). Only 1 nevus with archi- tectural disorder was strongly positive. The immu- noreactivity in the positive cases was restricted to the deep dermal component. Two pigmented spin- dle cell nevi were negative. Neither anti-S100A2 nor MAC387 antibodies reacted with the nevus cells. However, anti-S100A2 and MAC387 antibodies were observed in a few cells in the basal and upper layers of the epidermis, respectively. HMB45 was positive in the junctional component of the nevi FIGURE 2. Spitz nevus. As in Figure 1, this photograph shows a strong and uniform reactivity with the monoclonal antibody against and in scattered nevus cells in the dermis. Blue nevi S100A6 protein in the nevus cells. were strongly positive throughout. The differences observed in the number of posi- tive cells for anti-S100A6 antibody in Spitz nevi, melanomas, and melanocytic nevi cases were sta- tistically significant, either comparing the three en- tities as whole groups (P Ͻ .001) or comparing more similar histologic subgroups as junctional Spitz ne- vi–melanoma in situ (P Ͻ .001) and Spitz nevi– nodular melanoma (P Ͻ .001).
Recommended publications
  • Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino-Like Mouse Models: Tracking the Role of the Hairless Gene
    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Doctoral Dissertations Graduate School 5-2006 Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino-like Mouse Models: Tracking the Role of the Hairless Gene Yutao Liu University of Tennessee - Knoxville Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss Part of the Life Sciences Commons Recommended Citation Liu, Yutao, "Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino- like Mouse Models: Tracking the Role of the Hairless Gene. " PhD diss., University of Tennessee, 2006. https://trace.tennessee.edu/utk_graddiss/1824 This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. To the Graduate Council: I am submitting herewith a dissertation written by Yutao Liu entitled "Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino-like Mouse Models: Tracking the Role of the Hairless Gene." I have examined the final electronic copy of this dissertation for form and content and recommend that it be accepted in partial fulfillment of the requirements for the degree of Doctor of Philosophy, with a major in Life Sciences. Brynn H. Voy, Major Professor We have read this dissertation and recommend its acceptance: Naima Moustaid-Moussa, Yisong Wang, Rogert Hettich Accepted for the Council: Carolyn R.
    [Show full text]
  • Critical Evaluation of the So-Called “Junction Nevus”
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector CRITICAL EVALUATION OF THE SO-CALLED "JUNCTION NEVUS* S. WILLIAM BECKER, MS., M.D. The serious study of pigmented nevi was undertaken by many workers in the closing years of the 19th Century. All recognized that the microscopic picture of nevi differed from anything seen in other organs. The presence of nevus cells in both the epidermis and dermis led to concepts of origin at one or the other site, or at both sites. Dermal Origin: Demieville (1) believed that the nevus cells arose from adven- titial and endothelial cells of blood vessels. Bauer (2) and vonRecklinghausen (3) thought that the origin was from endothelium of lymph vessels rather than of blood vessels. Epidermal Origin: According to Abesser (4), Duranti, in 1871, was the first to suggest an epidermal origin of nevus cells. Kromayer (5) stated that the endo- thelium-like cells originate in the basal portion of the epidermis as "Bläschen- zellen", migrate to the dermis and develop connective tissue and elastic fibers, a change which he called "desmoplasia". Abesser (4) agreed that the cells origi- ated in the epithelium and lost their intercellular bridges, but migrated into the dermis as epithelium-like cells, and remained such. Unna (6) advanced the concept that the epithelial cells changed by losing their intercellular bridges and multiplied in groups, a process which he called "Ab- sonderung", then migrated as groups to the dermis, which he called "Abtrop- fung", thus forming pigmented nevi.
    [Show full text]
  • Atypical Mole Syndrome and Dysplastic Nevi: Identification of Populations at Risk for Developing Melanoma - Review Article
    CLINICS 2011;66(3):493-499 DOI:10.1590/S1807-59322011000300023 REVIEW Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma - review article Juliana Hypo´ lito Silva,I Bianca Costa Soares de Sa´,II Alexandre Leon Ribeiro de A´ vila,II Gilles Landman,III Joa˜ o Pedreira Duprat NetoII I Oncology School Celestino Bourroul - Hospital AC Camargo, Sa˜ o Paulo, SP, Brazil. II Skin Oncology Department - Hospital AC Camargo - Sa˜ o Paulo, SP, Brazil. III Pathology Department - Hospital AC Camargo - Sa˜ o Paulo, SP, Brazil. Atypical Mole Syndrome is the most important phenotypic risk factor for developing cutaneous melanoma, a malignancy that accounts for about 80% of deaths from skin cancer. Because the diagnosis of melanoma at an early stage is of great prognostic relevance, the identification of Atypical Mole Syndrome carriers is essential, as well as the creation of recommended preventative measures that must be taken by these patients. KEYWORDS: Dysplastic Nevus Syndrome; dysplastic nevi; melanoma; early diagnosis; Risk Factors. Silva JH, de Sa´ BC, Avila ALR, Landman G, Duprat Neto JP. Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma - review article. Clinics. 2011;66(3):493-499. Received for publication on November 23, 2010; First review completed on November 24, 2010; Accepted for publication on November 24, 2010 E-mail: [email protected] Tel.: 55 11 2189-5135 INTRODUCTION Several studies have shown that the presence of dysplas- tic nevi considerably increases the risk of developing The incidence of cutaneous melanoma has increased melanoma, which demonstrates that these lesions, aside rapidly worldwide.1-5 Although it corresponds to only 4% of 4 from being precursors to disease are also important risk all skin cancers, it accounts for 80% of skin cancer deaths.
    [Show full text]
  • Peripherally Generated Foxp3+ Regulatory T Cells Mediate the Immunomodulatory Effects of Ivig in Allergic Airways Disease
    Peripherally Generated Foxp3+ Regulatory T Cells Mediate the Immunomodulatory Effects of IVIg in Allergic Airways Disease This information is current as Amir H. Massoud, Gabriel N. Kaufman, Di Xue, Marianne of September 26, 2021. Béland, Marieme Dembele, Ciriaco A. Piccirillo, Walid Mourad and Bruce D. Mazer J Immunol published online 20 February 2017 http://www.jimmunol.org/content/early/2017/02/18/jimmun ol.1502361 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2017/02/18/jimmunol.150236 Material 1.DCSupplemental http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 26, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2017 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published February 20, 2017, doi:10.4049/jimmunol.1502361 The Journal of Immunology Peripherally Generated Foxp3+ Regulatory T Cells Mediate the Immunomodulatory Effects of IVIg in Allergic Airways Disease Amir H. Massoud,*,†,1 Gabriel N. Kaufman,* Di Xue,* Marianne Be´land,* Marieme Dembele,* Ciriaco A.
    [Show full text]
  • 1 Supporting Information for a Microrna Network Regulates
    Supporting Information for A microRNA Network Regulates Expression and Biosynthesis of CFTR and CFTR-ΔF508 Shyam Ramachandrana,b, Philip H. Karpc, Peng Jiangc, Lynda S. Ostedgaardc, Amy E. Walza, John T. Fishere, Shaf Keshavjeeh, Kim A. Lennoxi, Ashley M. Jacobii, Scott D. Rosei, Mark A. Behlkei, Michael J. Welshb,c,d,g, Yi Xingb,c,f, Paul B. McCray Jr.a,b,c Author Affiliations: Department of Pediatricsa, Interdisciplinary Program in Geneticsb, Departments of Internal Medicinec, Molecular Physiology and Biophysicsd, Anatomy and Cell Biologye, Biomedical Engineeringf, Howard Hughes Medical Instituteg, Carver College of Medicine, University of Iowa, Iowa City, IA-52242 Division of Thoracic Surgeryh, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada-M5G 2C4 Integrated DNA Technologiesi, Coralville, IA-52241 To whom correspondence should be addressed: Email: [email protected] (M.J.W.); yi- [email protected] (Y.X.); Email: [email protected] (P.B.M.) This PDF file includes: Materials and Methods References Fig. S1. miR-138 regulates SIN3A in a dose-dependent and site-specific manner. Fig. S2. miR-138 regulates endogenous SIN3A protein expression. Fig. S3. miR-138 regulates endogenous CFTR protein expression in Calu-3 cells. Fig. S4. miR-138 regulates endogenous CFTR protein expression in primary human airway epithelia. Fig. S5. miR-138 regulates CFTR expression in HeLa cells. Fig. S6. miR-138 regulates CFTR expression in HEK293T cells. Fig. S7. HeLa cells exhibit CFTR channel activity. Fig. S8. miR-138 improves CFTR processing. Fig. S9. miR-138 improves CFTR-ΔF508 processing. Fig. S10. SIN3A inhibition yields partial rescue of Cl- transport in CF epithelia.
    [Show full text]
  • Digital Epiluminescence Microscopy Monitoring of High-Risk Patients
    STUDY Digital Epiluminescence Microscopy Monitoring of High-Risk Patients June K. Robinson, MD; Brian J. Nickoloff, MD, PhD Objective: To examine the outcome of digital epilumi- dence in and comfort with dermatologic surveillance and nescence microscopic (DELM) surveillance of atypical skin self-examination performance were assessed. nevi in a high-risk population for 4 years. Results: During annual surveillance with DELM, 5.5% of Design: Atypical, flat melanocytic lesions in 100 pa- the lesions changed. Among the 193 excisional biopsy speci- tients at high risk of developing melanoma were fol- mens there were 4 melanomas in situ, 169 dysplastic nevi, lowed annually with DELM. Pigmentary changes or an and 20 common nevi. Confidence in and comfort with sur- increase in DELM diameter of 1 mm or greater was an veillance and skin self-examination improved after DELM. indication to perform an excisional biopsy. Conclusions: The criteria applied to detect substantial Setting: Cardinal Bernardin Cancer Center Melanoma DELM changes were an increase in DELM diameter of 1 Program, Loyola University Health System, Maywood. mm or greater and pigmentary changes, including ra- dial streaming, focal enlargement, peripheral black dots, Patients: A consecutive sample of 3482 lesions from 100 and “clumping” within the irregular pigment network. patients (aged 18-65 years) with at least 2 images of the Use of DELM enhanced confidence in and comfort with same lesion. care, which extended to performing more extensive skin self-examination. Main Outcome Measures:
    [Show full text]
  • S41467-020-18249-3.Pdf
    ARTICLE https://doi.org/10.1038/s41467-020-18249-3 OPEN Pharmacologically reversible zonation-dependent endothelial cell transcriptomic changes with neurodegenerative disease associations in the aged brain Lei Zhao1,2,17, Zhongqi Li 1,2,17, Joaquim S. L. Vong2,3,17, Xinyi Chen1,2, Hei-Ming Lai1,2,4,5,6, Leo Y. C. Yan1,2, Junzhe Huang1,2, Samuel K. H. Sy1,2,7, Xiaoyu Tian 8, Yu Huang 8, Ho Yin Edwin Chan5,9, Hon-Cheong So6,8, ✉ ✉ Wai-Lung Ng 10, Yamei Tang11, Wei-Jye Lin12,13, Vincent C. T. Mok1,5,6,14,15 &HoKo 1,2,4,5,6,8,14,16 1234567890():,; The molecular signatures of cells in the brain have been revealed in unprecedented detail, yet the ageing-associated genome-wide expression changes that may contribute to neurovas- cular dysfunction in neurodegenerative diseases remain elusive. Here, we report zonation- dependent transcriptomic changes in aged mouse brain endothelial cells (ECs), which pro- minently implicate altered immune/cytokine signaling in ECs of all vascular segments, and functional changes impacting the blood–brain barrier (BBB) and glucose/energy metabolism especially in capillary ECs (capECs). An overrepresentation of Alzheimer disease (AD) GWAS genes is evident among the human orthologs of the differentially expressed genes of aged capECs, while comparative analysis revealed a subset of concordantly downregulated, functionally important genes in human AD brains. Treatment with exenatide, a glucagon-like peptide-1 receptor agonist, strongly reverses aged mouse brain EC transcriptomic changes and BBB leakage, with associated attenuation of microglial priming. We thus revealed tran- scriptomic alterations underlying brain EC ageing that are complex yet pharmacologically reversible.
    [Show full text]
  • The UVB-Induced Gene Expression Profile of Human Epidermis in Vivo Is Different from That of Cultured Keratinocytes
    Oncogene (2006) 25, 2601–2614 & 2006 Nature Publishing Group All rights reserved 0950-9232/06 $30.00 www.nature.com/onc ORIGINAL ARTICLE The UVB-induced gene expression profile of human epidermis in vivo is different from that of cultured keratinocytes CD Enk1, J Jacob-Hirsch2, H Gal3, I Verbovetski4, N Amariglio2, D Mevorach4, A Ingber1, D Givol3, G Rechavi2 and M Hochberg1 1Department of Dermatology, The Hadassah-Hebrew University Medical Center, Jerusalem, Israel; 2Department of Pediatric Hemato-Oncology and Functional Genomics, Safra Children’s Hospital, Sheba Medical Center and Sackler School of Medicine, Tel-Aviv University,Tel Aviv, Israel; 3Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel and 4The Laboratory for Cellular and Molecular Immunology, Department of Medicine, The Hadassah-Hebrew University Medical Center, Jerusalem, Israel In order to obtain a comprehensive picture of the radiation. UVB, with a wavelength range between 290 molecular events regulating cutaneous photodamage of and 320 nm, represents one of the most important intact human epidermis, suction blister roofs obtained environmental hazards affectinghuman skin (Hahn after a single dose of in vivo ultraviolet (UV)B exposure and Weinberg, 2002). To protect itself against the were used for microarray profiling. We found a changed DNA-damaging effects of sunlight, the skin disposes expression of 619 genes. Half of the UVB-regulated genes over highly complicated cellular programs, including had returned to pre-exposure baseline levels at 72 h, cell-cycle arrest, DNA repair and apoptosis (Brash et al., underscoring the transient character of the molecular 1996). Failure in selected elements of these defensive cutaneous UVB response.
    [Show full text]
  • Melanomas Are Comprised of Multiple Biologically Distinct Categories
    Melanomas are comprised of multiple biologically distinct categories, which differ in cell of origin, age of onset, clinical and histologic presentation, pattern of metastasis, ethnic distribution, causative role of UV radiation, predisposing germ line alterations, mutational processes, and patterns of somatic mutations. Neoplasms are initiated by gain of function mutations in one of several primary oncogenes, typically leading to benign melanocytic nevi with characteristic histologic features. The progression of nevi is restrained by multiple tumor suppressive mechanisms. Secondary genetic alterations override these barriers and promote intermediate or overtly malignant tumors along distinct progression trajectories. The current knowledge about pathogenesis, clinical, histological and genetic features of primary melanocytic neoplasms is reviewed and integrated into a taxonomic framework. THE MOLECULAR PATHOLOGY OF MELANOMA: AN INTEGRATED TAXONOMY OF MELANOCYTIC NEOPLASIA Boris C. Bastian Corresponding Author: Boris C. Bastian, M.D. Ph.D. Gerson & Barbara Bass Bakar Distinguished Professor of Cancer Biology Departments of Dermatology and Pathology University of California, San Francisco UCSF Cardiovascular Research Institute 555 Mission Bay Blvd South Box 3118, Room 252K San Francisco, CA 94158-9001 [email protected] Key words: Genetics Pathogenesis Classification Mutation Nevi Table of Contents Molecular pathogenesis of melanocytic neoplasia .................................................... 1 Classification of melanocytic neoplasms
    [Show full text]
  • S100A6 and Its Brain Ligands in Neurodegenerative Disorders
    International Journal of Molecular Sciences Review S100A6 and Its Brain Ligands in Neurodegenerative Disorders Anna Filipek * and Wiesława Le´sniak Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur Street, 02-093 Warsaw, Poland; [email protected] * Correspondence: a.fi[email protected] Received: 13 May 2020; Accepted: 29 May 2020; Published: 1 June 2020 Abstract: The S100A6 protein is present in different mammalian cells and tissues including the brain. It binds Ca2+ and Zn2+ and interacts with many target proteins/ligands. The best characterized ligands of S100A6, expressed at high level in the brain, include CacyBP/SIP and Sgt1. Research concerning the functional role of S100A6 and these two ligands indicates that they are involved in various signaling pathways that regulate cell proliferation, differentiation, cytoskeletal organization, and others. In this review, we focused on the expression/localization of these proteins in the brain and on their possible role in neurodegenerative diseases. Published results demonstrate that S100A6, CacyBP/SIP, and Sgt1 are expressed in various brain structures and in the spinal cord and can be found in different cell types including neurons and astrocytes. When it comes to their possible involvement in nervous system pathology, it is evident that their expression/level and/or subcellular localization is changed when compared to normal conditions. Among diseases in which such changes have been observed are Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), epileptogenesis, Parkinson’s disease (PD), Huntington’s disease (HD), and others. Keywords: S100A6; CacyBP/SIP; Sgt1; neurodegeneration; β amyloid plaques; neurofibrillary tangles; Lewy bodies 1.
    [Show full text]
  • S100A6, a Calcium- and Zinc-Binding Protein, Is Overexpressed in SOD1 Mutant Mice, a Model for Amyotrophic Lateral Sclerosis
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biochimica et Biophysica Acta 1498 (2000) 264^272 www.elsevier.com/locate/bba S100A6, a calcium- and zinc-binding protein, is overexpressed in SOD1 mutant mice, a model for amyotrophic lateral sclerosis Daphne¨ Hoyaux a, Jules Alao a, Julia Fuchs b, Robert Kiss a, Bernhard Keller b, Claus W. Heizmann c, Roland Pochet a;*, Detlev Frermann a; b a Laboratory of Histopathology, Faculty of Medicine, Universite¨ Libre de Bruxelles, CP 620, 808 route de Lennik, 1070 Brussels, Belgium b Center of Physiology, Department of Neuro- and Sense Physiology, University of Go«ttingen, Go«ttingen, Germany c Division of Clinical Chemistry and Biochemistry, Department of Pediatrics, University of Zu«rich, Zu«rich, Switzerland Received 11 September 2000; accepted 12 September 2000 Abstract Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterised by selective degeneration of motoneurones. Familial ALS is an age-dependent autosomal dominant disorder in which mutations in the homodimeric enzyme Cu/Zn superoxide dismutase 1 (SOD1) is linked to the disease. An animal model for this disease is a transgenic mouse expressing the mutated human SOD1G93A gene. Recent electrophysiological data emphasised that the striking selective vulnerability of motoneurones might be due to their differential calcium buffering capacities. Therefore we have investigated, using immunohistochemistry, the expression of different calcium binding proteins in brainstem and spinal cord from normal and SOD1 mutated mice. Among the 13 calcium-binding proteins screened, only one, S100A6, a homodimeric calcium- binding protein able to bind four Zn2, appeared to be highly expressed in the SOD1 mutated mice.
    [Show full text]
  • A Search for CDKN2A/P16ink4a Mutations in Melanocytic Nevi from Patients with Melanoma and Spouse Controls by Use of Laser-Captured Microdissection
    STUDY A Search for CDKN2A/p16INK4a Mutations in Melanocytic Nevi From Patients With Melanoma and Spouse Controls by Use of Laser-Captured Microdissection Hao Wang, MD, PhD; Richard B. Presland, PhD; Michael Piepkorn, MD, PhD Objective: To determine the frequency at which the CDKN2A were observed in any of the melanocytic CDKN2A coding region is mutated in the atypical nevi nevi. of persons with sporadic melanoma. Conclusions: Point mutations in CDKN2A are an un- Design: DNA samples, isolated by laser-captured mi- common event in the atypical nevi of persons with mela- crodissection of atypical nevi from 10 patients with newly noma. As such, the data may support a hypothesis of incident cases of sporadic melanoma and their spouses melanocytic nevus histogenesis, in which the melano- as matched controls, were used as templates for nested cytic nevus and malignant melanoma represent sepa- polymerase chain reaction amplification of CDKN2A rate, pleiotropic pathways resulting from common stimuli, exons 1 and 2. such as genomic damage from UV radiation. Results: No point mutations in the coding region of Arch Dermatol. 2005;141:177-180 ONCEPTUAL MODELS OF messenger RNA are expressed at seem- melanoma development ingly normal levels in atypical as well as ba- and progression incorpo- nal nevi, but at significantly reduced lev- rate common and atypi- els in many melanomas, including the cal (dysplastic) nevi as po- earliest recognizable stage, melanoma in Ctential stages in the evolution of the situ.3-5 Moreover, the phenotype of mul- malignant phenotype in melanocytic sys- tiple and/or enlarged nevi does not geneti- tems.1 Support for this hypothesis can be cally segregate with, nor readily link by found, among other lines of evidence, in the polymorphic markers to, the CDKN2A lo- 6,7 spatial coexistence of melanoma and nevi cus.
    [Show full text]